Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:1904001rdf:typepubmed:Citationlld:pubmed
pubmed-article:1904001lifeskim:mentionsumls-concept:C0027651lld:lifeskim
pubmed-article:1904001lifeskim:mentionsumls-concept:C0001554lld:lifeskim
pubmed-article:1904001lifeskim:mentionsumls-concept:C0596972lld:lifeskim
pubmed-article:1904001lifeskim:mentionsumls-concept:C0232338lld:lifeskim
pubmed-article:1904001lifeskim:mentionsumls-concept:C0025519lld:lifeskim
pubmed-article:1904001lifeskim:mentionsumls-concept:C0024730lld:lifeskim
pubmed-article:1904001lifeskim:mentionsumls-concept:C0017725lld:lifeskim
pubmed-article:1904001lifeskim:mentionsumls-concept:C1709059lld:lifeskim
pubmed-article:1904001lifeskim:mentionsumls-concept:C0877853lld:lifeskim
pubmed-article:1904001lifeskim:mentionsumls-concept:C1521743lld:lifeskim
pubmed-article:1904001lifeskim:mentionsumls-concept:C0181904lld:lifeskim
pubmed-article:1904001lifeskim:mentionsumls-concept:C1704646lld:lifeskim
pubmed-article:1904001lifeskim:mentionsumls-concept:C0728873lld:lifeskim
pubmed-article:1904001lifeskim:mentionsumls-concept:C0444498lld:lifeskim
pubmed-article:1904001lifeskim:mentionsumls-concept:C0591833lld:lifeskim
pubmed-article:1904001lifeskim:mentionsumls-concept:C1553628lld:lifeskim
pubmed-article:1904001pubmed:issue12lld:pubmed
pubmed-article:1904001pubmed:dateCreated1991-7-10lld:pubmed
pubmed-article:1904001pubmed:abstractTextThe hyperglycemia-induced in situ metabolism and blood flow changes produced in s.c. implanted murine radiation-induced fibrosarcoma-1 tumors, grown on the flanks of female C3H/HeJ mice, were examined with 31P and 2H nuclear magnetic resonance. Initial experiments verified a hyperglycemic tumor acidification similar to that reported earlier with a different substrain of mice, C3H/AnF (J.L. Evelhoch et al., Proc. Natl. Acad. Sci. USA, 81: 6496-6500, 1984). Changes in the tumor pH, phosphorus metabolites, and blood flow were then compared after administration of saline, glucose, or mannitol (a nonmetabolizable glucose analogue) using a mole-equivalent dose of the sugars (i.e., 0.8 mmol/20g mouse). Neither saline (n = 8) nor mannitol (n = 6) administration had any marked effect upon tumor pH, whereas glucose administration produced a mean maximum tumor pH reduction of 0.74 +/- 0.09 (SE; n = 9) during the 2.5 h post-glucose injection. No significant changes in high energy phosphate concentrations were observed during the same period after saline injection. After glucose injection, the [phosphocreatine] gradually decreased by 64% (P = 0.0001). After the initial 1 h post-glucose injection, the [inorganic phosphate] increased by 58% (P = 0.0001), and the [nucleoside triphosphates] decreased by 29% (P = 0.0001) during the following 1.5 h. After mannitol injection, while there was no change in [inorganic phosphate] over time (P = 0.37), the [phosphocreatine] decreased by 33% (P = 0.0001) and the [nucleoside triphosphates] decreased by 21% (P = 0.0015) within 20 min, then both the [phosphocreatine] and [nucleoside triphosphates] remained at constant levels during the following 2 h. In parallel experiments, the volumetric rate of tumor blood flow and perfusion was measured by 2H nuclear magnetic resonance monitoring of 2H2O washout kinetics (S-G. Kim and J. J. H. Ackerman, Cancer Res., 48: 3449-3453, 1988); tumor blood flow decreased by 80% (P = 0.0001, n = 11), 60% (P = 0.0031, n = 4), and 20% (P = 0.058, n = 10) at 2 h after glucose, mannitol, or saline injections, respectively. These results suggest that anaerobic glycolysis is a requirement for hyperglycemic tumor acidification. However, the decrease in tumor blood flow accompanying hyperglycemic acidification suggests that flow reduction also may be a contributing or a required cofactor for acidification via inhibition of lactic acid egress.(ABSTRACT TRUNCATED AT 400 WORDS)lld:pubmed
pubmed-article:1904001pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1904001pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1904001pubmed:languageenglld:pubmed
pubmed-article:1904001pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1904001pubmed:citationSubsetIMlld:pubmed
pubmed-article:1904001pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1904001pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1904001pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1904001pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1904001pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1904001pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1904001pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1904001pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1904001pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1904001pubmed:statusMEDLINElld:pubmed
pubmed-article:1904001pubmed:monthJunlld:pubmed
pubmed-article:1904001pubmed:issn0008-5472lld:pubmed
pubmed-article:1904001pubmed:authorpubmed-author:FEYH GHGlld:pubmed
pubmed-article:1904001pubmed:authorpubmed-author:HwangY CYClld:pubmed
pubmed-article:1904001pubmed:authorpubmed-author:AckermanJ JJJlld:pubmed
pubmed-article:1904001pubmed:authorpubmed-author:SeyedsadrMMlld:pubmed
pubmed-article:1904001pubmed:authorpubmed-author:EvelhochJ LJLlld:pubmed
pubmed-article:1904001pubmed:issnTypePrintlld:pubmed
pubmed-article:1904001pubmed:day15lld:pubmed
pubmed-article:1904001pubmed:volume51lld:pubmed
pubmed-article:1904001pubmed:ownerNLMlld:pubmed
pubmed-article:1904001pubmed:authorsCompleteYlld:pubmed
pubmed-article:1904001pubmed:pagination3108-18lld:pubmed
pubmed-article:1904001pubmed:dateRevised2007-11-14lld:pubmed
pubmed-article:1904001pubmed:meshHeadingpubmed-meshheading:1904001-...lld:pubmed
pubmed-article:1904001pubmed:meshHeadingpubmed-meshheading:1904001-...lld:pubmed
pubmed-article:1904001pubmed:meshHeadingpubmed-meshheading:1904001-...lld:pubmed
pubmed-article:1904001pubmed:meshHeadingpubmed-meshheading:1904001-...lld:pubmed
pubmed-article:1904001pubmed:meshHeadingpubmed-meshheading:1904001-...lld:pubmed
pubmed-article:1904001pubmed:meshHeadingpubmed-meshheading:1904001-...lld:pubmed
pubmed-article:1904001pubmed:meshHeadingpubmed-meshheading:1904001-...lld:pubmed
pubmed-article:1904001pubmed:meshHeadingpubmed-meshheading:1904001-...lld:pubmed
pubmed-article:1904001pubmed:meshHeadingpubmed-meshheading:1904001-...lld:pubmed
pubmed-article:1904001pubmed:meshHeadingpubmed-meshheading:1904001-...lld:pubmed
pubmed-article:1904001pubmed:meshHeadingpubmed-meshheading:1904001-...lld:pubmed
pubmed-article:1904001pubmed:meshHeadingpubmed-meshheading:1904001-...lld:pubmed
pubmed-article:1904001pubmed:meshHeadingpubmed-meshheading:1904001-...lld:pubmed
pubmed-article:1904001pubmed:meshHeadingpubmed-meshheading:1904001-...lld:pubmed
pubmed-article:1904001pubmed:meshHeadingpubmed-meshheading:1904001-...lld:pubmed
pubmed-article:1904001pubmed:meshHeadingpubmed-meshheading:1904001-...lld:pubmed
pubmed-article:1904001pubmed:meshHeadingpubmed-meshheading:1904001-...lld:pubmed
pubmed-article:1904001pubmed:meshHeadingpubmed-meshheading:1904001-...lld:pubmed
pubmed-article:1904001pubmed:meshHeadingpubmed-meshheading:1904001-...lld:pubmed
pubmed-article:1904001pubmed:meshHeadingpubmed-meshheading:1904001-...lld:pubmed
pubmed-article:1904001pubmed:meshHeadingpubmed-meshheading:1904001-...lld:pubmed
pubmed-article:1904001pubmed:meshHeadingpubmed-meshheading:1904001-...lld:pubmed
pubmed-article:1904001pubmed:year1991lld:pubmed
pubmed-article:1904001pubmed:articleTitleModulation of murine radiation-induced fibrosarcoma-1 tumor metabolism and blood flow in situ via glucose and mannitol administration monitored by 31P and 2H nuclear magnetic resonance spectroscopy.lld:pubmed
pubmed-article:1904001pubmed:affiliationDepartment of Chemistry, Washington University, St. Louis, Missouri 63130.lld:pubmed
pubmed-article:1904001pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:1904001pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:1904001pubmed:publicationTypeResearch Support, U.S. Gov't, Non-P.H.S.lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1904001lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1904001lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1904001lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1904001lld:pubmed